What is the current Intrasaccular Embolization System market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Intrasaccular Embolization System market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Intrasaccular Embolization System market?

Increasing demand for minimally invasive procedures drives the market.

What are the major challenges facing the Intrasaccular Embolization System market?

High procedural costs and limited awareness are significant challenges.

Which regions are the leaders in the Intrasaccular Embolization System market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Intrasaccular Embolization System market?

Top companies include Medtronic and Stryker, among others.

What are the future opportunities in the Intrasaccular Embolization System market?

Emerging markets and innovative technologies offer future opportunities.

How does technology impact the Intrasaccular Embolization System market?

Advances in medical technology improve procedure outcomes and efficiency.

What is the current regulatory landscape for the Intrasaccular Embolization System market?

Stringent regulations and safety standards govern the market.

What is the future outlook for the Intrasaccular Embolization System market?

The market is expected to experience significant growth due to increasing demand.

What Is the Global Intrasaccular Embolization System Market Worth in 2026?

Intrasaccular Embolization System by Application (Hospitals, Speciality Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others), by Types (Embolic Coils, Woven EndoBridge (WEB), Medina Embolization Device, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 78

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 78

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Intrasaccular Embolization System Market Overview

The Intrasaccular Embolization System market refers to the industry focused on developing and commercializing devices used for the treatment of cerebral aneurysms. As a critical component of neurointerventional procedures, the Intrasaccular Embolization System market size is estimated to be around $443 million, with a growth outlook that is increasingly positive due to advancements in medical technology and an aging population. The market forecast indicates a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033, driven by macro drivers such as the rising prevalence of cerebral aneurysms, increased awareness about available treatments, and the expansion of healthcare infrastructure in emerging economies. The industry expansion is further fueled by technological shifts, evolving consumer behavior, and regulatory environments that support innovation.

Loading chart…

Key forces shaping the Intrasaccular Embolization System industry include technological advancements in device miniaturization and biocompatibility, regulatory approvals and clearances that facilitate market entry for new products, and competitive intensity driven by established players and new entrants. The largest region for the Intrasaccular Embolization System market is currently North America, while the fastest-growing region is anticipated to be Asia-Pacific, driven by healthcare system expansions and increasing demand for advanced neurointerventional treatments. As the market continues to evolve, understanding these dynamics will be crucial for strategic planners, business development teams, and C-suite executives seeking to navigate the opportunities and challenges within the Intrasaccular Embolization System market.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	5.00 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MicroVention, Inc. (Terumo); Medtronic; Braile Biomedica; Stryker; Cook Medical; Kaneka
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Intrasaccular Embolization System market is poised for significant growth, driven by factors influencing its size and growth forecast. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Advancements in medical technology, such as improved device materials and designs, are enhancing the efficacy and safety of Intrasaccular Embolization System procedures, leading to increased adoption rates among healthcare providers.

Growing awareness and understanding of the benefits of minimally invasive treatments are driving patient demand for Intrasaccular Embolization System market solutions, further fueling market expansion.

Restraints2 items

High development costs and stringent regulatory requirements are barriers to entry for new competitors in the Intrasaccular Embolization System market, potentially limiting market growth by reducing competition and innovation.

Reimbursement challenges and variability in insurance coverage for Intrasaccular Embolization System procedures can hinder market penetration, especially in regions with rigid healthcare reimbursement policies.

Opportunities2 items

Emerging markets, particularly in Asia-Pacific and Latin America, present significant opportunities for Intrasaccular Embolization System market players due to their large and growing patient populations and increasing healthcare expenditures.

The trend towards personalized medicine and the integration of Intrasaccular Embolization System with other therapies offer opportunities for market players to develop innovative, tailored treatment solutions, enhancing patient outcomes and market demand.

Challenges2 items

Maintaining profitability in a competitive Intrasaccular Embolization System market environment, characterized by pricing pressures and high research and development expenditures, is a significant challenge for market participants.

Ensuring the long-term safety and efficacy of Intrasaccular Embolization System devices, given the complex nature of the procedures and the materials used, is essential but challenging, requiring extensive clinical trials and post-market surveillance.

Market Segmentation

Loading chart…

The Intrasaccular Embolization System market can be segmented based on Application, which includes subtypes such as cerebral aneurysms, arteriovenous malformations (AVMs), and dural arteriovenous fistulas (DAVFs). The application segment contributes significantly to the overall Intrasaccular Embolization System market size, with cerebral aneurysms being the largest contributor due to the high prevalence of this condition. Understanding the Intrasaccular Embolization System segmentation is crucial for market players to develop targeted strategies and products that cater to specific patient needs.

Another key segmentation category for the Intrasaccular Embolization System market is Types, which includes subtypes such as flow diverters, intrasaccular devices, and microcoils. The types segment is expected to drive growth in the Intrasaccular Embolization System market, with flow diverters being the fastest-growing subtype due to their increasing adoption in the treatment of cerebral aneurysms. The market taxonomy of the Intrasaccular Embolization System market is complex, with each subtype having its own set of advantages and disadvantages, and market players must carefully analyze these segments to stay competitive.

Intrasaccular Embolization System Segmentation Breakdown11 items

Application

Hospitals

Speciality Clinics

Ambulatory Surgical Centers

Diagnostic Centers

Others

Types

Embolic Coils

Woven EndoBridge (WEB)

Medina Embolization Device

Others

Regional Insights

Loading chart…

The Intrasaccular Embolization System market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be the Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for the North America region include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, growing demand for minimally invasive procedures, and increasing focus on patient outcomes. The Asia Pacific region is driven by a large and growing population, increasing access to healthcare, and rising awareness of intrasaccular embolization systems.

In Latin America, key drivers include a growing middle class, increasing investment in healthcare, and a rising need for advanced medical treatments. The Middle East & Africa region is driven by a growing population, increasing investment in healthcare infrastructure, and a rising demand for specialized medical services. Understanding these regional dynamics is crucial for regional forecast and Intrasaccular Embolization System market growth.

Competitive Landscape

The Intrasaccular Embolization System market is moderately consolidated, driven by a mix of global players and local companies. The Intrasaccular Embolization System competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on leveraging their extensive distribution networks and product portfolios to maintain their market presence, while local companies concentrate on regional expansion and customization to cater to specific market needs.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies focus on developing innovative products, strengthening their channel presence, and offering customized solutions to enhance customer satisfaction and loyalty.

MicroVention, Inc. (Terumo): regional expansion

Medtronic: innovation pipeline

Braile Biomedica: premium pricing

Stryker: vertical integration

Cook Medical: OEM tie-ups

Kaneka: local manufacturing

Key Intrasaccular Embolization System Companies6 items

MicroVention, Inc. (Terumo)

Medtronic

Braile Biomedica

Stryker

Cook Medical

Kaneka

Market Ecosystem

The Intrasaccular Embolization System ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value creation and capture occur through the development, manufacturing, and deployment of intrasaccular embolization systems, with each participant playing a distinct role in the value chain analysis.

Raw material suppliers — providing components and materials

OEMs / manufacturers — designing and producing systems

Technology providers — developing underlying technologies

System integrators / EPCs — integrating systems and solutions

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing and enforcing standards

The flow of value within the Intrasaccular Embolization System ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can vary across regions, leading to differences in the ecosystem's structure and dynamics.

Recent Industry Insights

The Intrasaccular Embolization System industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product portfolios and expanding market reach. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the industry. Furthermore, several product and technology launches have been observed, showcasing advancements in embolization systems. Regulatory changes have also impacted the industry, with updated guidelines and approvals influencing the development and marketing of intrasaccular embolization systems. A shift in consumer trends towards minimally invasive procedures has driven demand for these systems, while funding rounds and expansions have supported research and development efforts.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Intrasaccular Embolization System market outlook. The market attractiveness is moderate, driven by increasing demand for minimally invasive procedures and advancements in medical technology. Competitive intensity is high, with established players and new entrants vying for market share. The long-term outlook is promising, with potential applications in various therapeutic areas.

The innovation landscape is dynamic, with ongoing research and development focused on improving device efficacy and safety. However, the demand–supply balance is a concern, with potential shortages of skilled professionals and high-quality devices. Key risk factors include regulatory challenges, reimbursement issues, and technological disruptions. Overall, the market presents opportunities for growth, but stakeholders must navigate these challenges to succeed.

11 items

1. Executive Summary

2. Intrasaccular Embolization System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intrasaccular Embolization System Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Intrasaccular Embolization System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Speciality Clinics

6.1.3. Ambulatory Surgical Centers

6.1.4. Diagnostic Centers

6.1.5. Others

6.2. Global Intrasaccular Embolization System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Embolic Coils

6.2.2. Woven EndoBridge (WEB)

6.2.3. Medina Embolization Device

6.2.4. Others

6.3. Global Intrasaccular Embolization System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Intrasaccular Embolization System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intrasaccular Embolization System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Intrasaccular Embolization System Market Competition by Key Manufacturers

8.1. Global Intrasaccular Embolization System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Intrasaccular Embolization System: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. MicroVention, Inc. (Terumo)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Medtronic

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Braile Biomedica

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Stryker

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cook Medical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Kaneka

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intrasaccular Embolization System Market

Figure 4: Global Intrasaccular Embolization System Market: Drivers

Figure 5: Global Intrasaccular Embolization System Market: Challenges

Figure 6: Global Intrasaccular Embolization System Market: Trends

Figure 7: Global Intrasaccular Embolization System Market: Opportunity

Figure 8: Global Intrasaccular Embolization System Market: Restraint

Figure 9: Global Intrasaccular Embolization System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Intrasaccular Embolization System Market Value (USD Million) By Region

Figure 15: Global Intrasaccular Embolization System Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Intrasaccular Embolization System Market Value (USD Million) By Region

Figure 23: Global Intrasaccular Embolization System Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Intrasaccular Embolization System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Intrasaccular Embolization System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Intrasaccular Embolization System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Intrasaccular Embolization System Market Value (USD Million) By Region

Table 10: Global Intrasaccular Embolization System Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Intrasaccular Embolization System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Intrasaccular Embolization System Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Intrasaccular Embolization System Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: MicroVention, Inc. (Terumo) Basic Information And Sales Area

Table 31: MicroVention, Inc. (Terumo). Products Portfolio

Table 32: Medtronic Basic Information And Sales Area

Table 33: Medtronic. Products Portfolio

Table 34: Braile Biomedica Basic Information And Sales Area

Table 35: Braile Biomedica. Products Portfolio

Table 36: Stryker Basic Information And Sales Area

Table 37: Stryker. Products Portfolio

Table 38: Cook Medical Basic Information And Sales Area

Table 39: Cook Medical. Products Portfolio

Table 40: Kaneka Basic Information And Sales Area

Table 41: Kaneka. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Intrasaccular Embolization System Market Value (USD Million) By Region

Table 47: Global Intrasaccular Embolization System Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Intrasaccular Embolization System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	5.00 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MicroVention, Inc. (Terumo); Medtronic; Braile Biomedica; Stryker; Cook Medical; Kaneka
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Intrasaccular Embolization System Segmentation Breakdown11 items

Application

Hospitals

Speciality Clinics

Ambulatory Surgical Centers

Diagnostic Centers

Others

Types

Embolic Coils

Woven EndoBridge (WEB)

Medina Embolization Device

Others

Regional Insights

Loading chart…

Competitive Landscape

MicroVention, Inc. (Terumo): regional expansion

Medtronic: innovation pipeline

Braile Biomedica: premium pricing

Stryker: vertical integration

Cook Medical: OEM tie-ups

Kaneka: local manufacturing

Key Intrasaccular Embolization System Companies6 items

MicroVention, Inc. (Terumo)

Medtronic

Braile Biomedica

Stryker

Cook Medical

Kaneka

Market Ecosystem

Raw material suppliers — providing components and materials

OEMs / manufacturers — designing and producing systems

Technology providers — developing underlying technologies

System integrators / EPCs — integrating systems and solutions

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing and enforcing standards

Recent Industry Insights

Analyst Overview

Table of Contents